| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
343,298 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,897,756 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
12 |
12 |
| Total Shares Sold |
1,129,833 |
1,419,857 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$62,474,611 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
27 |
27 |
76 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-25 |
4 |
S |
$1.56 |
$23,049 |
I/I |
(14,775) |
3,685,902 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-22 |
4 |
S |
$1.55 |
$4,030 |
I/I |
(2,600) |
3,700,677 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-21 |
4 |
S |
$1.55 |
$68,659 |
I/I |
(44,296) |
3,703,277 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-20 |
4 |
S |
$1.55 |
$63,440 |
I/I |
(40,929) |
3,747,573 |
|
- |
|
| Melincoff Gwen A |
Director |
– • – |
2019-11-19 |
4 |
B |
$1.54 |
$15,364 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-19 |
4 |
S |
$1.55 |
$930 |
I/I |
(600) |
3,788,502 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-18 |
4 |
S |
$1.55 |
$155 |
I/I |
(100) |
3,789,102 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-15 |
4 |
S |
$1.55 |
$79,676 |
I/I |
(51,404) |
3,789,202 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-14 |
4 |
S |
$1.55 |
$48,656 |
I/I |
(31,391) |
3,840,606 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-13 |
4 |
S |
$1.55 |
$22,055 |
I/I |
(14,229) |
3,871,997 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-05 |
4 |
S |
$1.55 |
$13,584 |
I/I |
(8,764) |
3,886,226 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-04 |
4 |
S |
$1.58 |
$339,198 |
I/I |
(214,682) |
3,894,990 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-11-01 |
4 |
S |
$1.55 |
$147,112 |
I/I |
(94,911) |
4,109,672 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-10-31 |
4 |
S |
$1.55 |
$38,477 |
I/I |
(24,824) |
4,204,583 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-10-28 |
4 |
S |
$1.55 |
$11,199 |
I/I |
(7,225) |
4,229,407 |
|
- |
|
| Schuler Jack W |
10% Owner |
– – • |
2019-10-25 |
4 |
B |
$1.20 |
$3,076,500 |
I/I |
2,563,750 |
6,217,345 |
1.5 |
- |
|
| Abingworth Llp |
10% Owner |
– – • |
2019-10-25 |
4 |
B |
$1.20 |
$2,760,000 |
I/I |
2,300,000 |
6,969,272 |
1.5 |
- |
|
| Sinclair Andrew |
Director |
– • – |
2019-10-25 |
4 |
B |
$1.20 |
$2,760,000 |
I/I |
2,300,000 |
6,969,272 |
2.1 |
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2019-10-24 |
4 |
S |
$1.60 |
$37,315 |
I/I |
(23,322) |
4,236,632 |
|
- |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2019-07-26 |
4 |
B |
$2.14 |
$16,070 |
I/I |
7,500 |
350,334 |
1.5 |
- |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2019-07-26 |
4 |
B |
$2.14 |
$106,207 |
I/I |
49,569 |
2,665,050 |
1.5 |
- |
|
| Schuler Jack W |
10% Owner |
– – • |
2019-05-20 |
4 |
B |
$1.93 |
$65,376 |
I/I |
33,900 |
835,717 |
1.5 |
- |
|
| Bioasia Investments Iv Llc |
10% Owner |
– – • |
2019-05-20 |
4 |
S |
$1.92 |
$151,292 |
I/I |
(78,798) |
0 |
|
- |
|
| Bioasia Investments Iv Llc |
10% Owner |
– – • |
2019-05-17 |
4 |
S |
$1.98 |
$23,613 |
I/I |
(11,926) |
68,942 |
|
- |
|
| Schuler Jack W |
10% Owner |
– – • |
2019-05-13 |
4 |
B |
$1.99 |
$20,991 |
I/I |
10,572 |
801,817 |
1.5 |
- |
|
386 Records found
|
|
Page 9 of 16 |
|
|
